MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis

Dong Cheng; Xubin Qiu; Ming Zhuang; Chenlei Zhu; Hongjun Zou; Zhiwei Liu

doi:10.18632/oncotarget.19009

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Meta-Analysis:

MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis

Dong Cheng, Xubin Qiu, Ming Zhuang, Chenlei Zhu, Hongjun Zou and Zhiwei Liu _

PDF | HTML | How to cite

Oncotarget. 2017; 8:81062-81074. https://doi.org/10.18632/oncotarget.19009

Metrics: PDF 1923 views | HTML 2627 views | ?

Abstract

Dong Cheng1, Xubin Qiu1, Ming Zhuang1, Chenlei Zhu1, Hongjun Zou1 and Zhiwei Liu1

1Department of Orthopedics, The Third Affiliated Hospital of Soochow University, Changzhou 213003, P.R. China

Correspondence to:

Zhiwei Liu, email: [email protected]

Keywords: microRNAs, osteosarcoma, prognosis

Received: March 22, 2017 Accepted: June 19, 2017 Published: July 05, 2017

ABSTRACT

Introduction: This study aimed to elucidate the prognostic value of microRNAs (miRNAs) in patients with osteosarcoma.

Materials and Methods: Studies were recruited by searching PubMed, Embase, the Cochrane Library, China National Knowledge Infrastructure, and Wanfang data-bases (final search update conducted January 2017). Eligible studies were identified and the quality was assessed using multiple search strategies.

Results: A total of 55 articles that investigated the correlation between miRNA expression and either patient survival or disease recurrence in osteosarcoma was initially identified. Among these, 30 studies were included in the meta-analysis. The results of our meta-analysis revealed that elevated levels of miR-21, miR-214, miR-29, miR-9 and miR-148a were associated with poor prognosis in osteosarcoma. Additionally, downregulated miR-382, miR26a, miR-126, miR-195 and miR-124 expression indicated poor prognosis in osteosarcoma.

Conclusions: miRNAs may act as independent prognostic factors in patients with osteosarcoma and are useful in stratifying risk.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 19009

Publication Alerts

Post-Publication Promotion

Publication Discount

Meta-Analysis:

MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis

Abstract